Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06457074

Finerenone for Patients With Primary Aldosteronism (FAIRY)

Finerenone for Patients With Primary Aldosteronism (FAIRY): A Multicenter, Randomized Clinical Trial

Sponsor: Changzhi Medical College

Interventions Finerenone Oral Tablet Spironolactone Oral Tablet

Updated 2 times since 2024 Last updated: Aug 28, 2024 Started: Jun 4, 2024 Primary completion: Jun 1, 2025 Completion: Jun 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Primary Aldosteronism and is currently actively recruiting participants. Changzhi Medical College leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4

First recorded

Jun 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changzhi Medical College
Qifu Li
Second Affiliated Hospital, School of Medicine, Zhejiang University
The Affiliated Hospital Of Southwest Medical University
The First Affiliated Hospital of Zhengzhou University

Data source: Chongqing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China